OTCMKTS:WXXWY

WuXi Biologics (Cayman) (WXXWY) Stock Forecast, Price & News

$11.48

+0.58 (+5.32%)

(As of 06/2/2023 ET)

Compare

Today's Range: $11.41
▼
$11.53
50-Day Range: $10.20
▼
$13.80
52-Week Range: $8.70
▼
$21.54

Volume: 57,501 shs
Average Volume: 56,642 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Analyst Ratings Chart Competitors Headlines Short Interest

About WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Stock

Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its services include testing; clinical drug substance cGMP manufacture; commercial drug substance cGMP manufacture; drug product cGMP fill and finish; antibody drug conjugates; regulatory affairs; and technologies and platforms. The company was founded on May 24, 2010 and is headquartered in Wuxi, China.

Receive WXXWY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WuXi Biologics (Cayman) and its competitors with MarketBeat's FREE daily newsletter.

WXXWY Stock News Headlines

June 1, 2023 | msn.com

WuXi Biologics to boost manufacturing capacity in Germany

June 1, 2023 | finance.yahoo.com

WuXi Biologics to Increase Manufacturing Capacity in Germany

June 3, 2023 | Chaikin Analytics (Ad)

Famous Wall Street Crash System Flashes RED

Hundreds of banks, hedge funds, and brokerages have paid $5,000 a month to access these alerts. Because when this system flashes on U.S. stocks, huge gains – and losses – can follow.

May 22, 2023 | finance.yahoo.com

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

May 16, 2023 | finance.yahoo.com

WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients

April 28, 2023 | finance.yahoo.com

WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability

April 28, 2023 | americanbankingnews.com

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Up 6,092.0% in April

April 17, 2023 | finance.yahoo.com

WuXi Biologics and WuXi XDC Congratulate DualityBio on Entering Global Licensing and Collaboration Agreements with BioNTech to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics

June 3, 2023 | Chaikin Analytics (Ad)

Famous Wall Street Crash System Flashes RED

Hundreds of banks, hedge funds, and brokerages have paid $5,000 a month to access these alerts. Because when this system flashes on U.S. stocks, huge gains – and losses – can follow.

March 29, 2023 | americanbankingnews.com

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

March 28, 2023 | finance.yahoo.com

WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease

March 3, 2023 | investopedia.com

Why Are the Cayman Islands Considered a Tax Haven?

January 17, 2023 | marketwatch.com

Wuxi Biologics Drops After Major Shareholder Plans to Sell 1.3% Stake

January 5, 2023 | msn.com

BRIEF-Wuxi Biologics And Gsk Enter Into License Agreement On Multiple Novel Bi- & Multi-Specific T Cell Engagers

January 4, 2023 | finance.yahoo.com

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

December 16, 2022 | marketwatch.com

Wuxi Biologics Shares Gain After Unit's Removal From U.S. 'Unverified List'

December 15, 2022 | finance.yahoo.com

WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List

December 15, 2022 | seekingalpha.com

WuXi Biologics: Spotlight On Positive Developments And Long-Term Concerns

December 15, 2022 | ca.finance.yahoo.com

U.S. Commerce removes Wuxi Biologics from unverified list

December 15, 2022 | finance.yahoo.com

CORRECTED-(OFFICIAL)-UPDATE 1-Biden blacklists China's YMTC, crackdowns on AI chip sector

November 21, 2022 | finance.yahoo.com

WuXi Biologics Launches an Integrated Biologics CRDMO Center in Fengxian, Shanghai

October 27, 2022 | finance.yahoo.com

WuXi Biologics Provides Corporate Updates

October 23, 2022 | finance.yahoo.com

WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities

October 18, 2022 | finance.yahoo.com

WuXi XDC Receives Best CMO Provider Runner Up Prize at 2022 World ADC Awards

October 14, 2022 | finance.yahoo.com

WuXi Biologics Receives "Best CDMO Award of the Year"

October 11, 2022 | finance.yahoo.com

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

October 9, 2022 | finance.yahoo.com

WuXi Biologics Co., Ltd. Removed from Unverified List

See More Headlines

WXXWY Price History

30 days | 90 days | 365 days | Advanced Chart

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:WXXWY
CUSIP: N/A
CIK: N/A
Web: www.wuxibiologics.com.cn
Phone: 8651081831205
Fax: N/A
Employees: 9,864
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Zhi Sheng Chen
Chief Executive Officer & Executive Director

Ming Tu
Chief Financial Officer & Executive Vice President

Weichang Zhou
Executive Director, Chief Technology Officer & EVP

Gu Jijie
Chief Scientific Officer & Executive VP

Yue Huang
Joint Secretary

Key Competitors

View All Competitors

WXXWY Stock - Frequently Asked Questions

Should I buy or sell WuXi Biologics (Cayman) stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for WuXi Biologics (Cayman) in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" WXXWY shares.
View WXXWY analyst ratings or view top-rated stocks.
How have WXXWY shares performed in 2023?: WuXi Biologics (Cayman)'s stock was trading at $15.07 on January 1st, 2023. Since then, WXXWY shares have decreased by 23.8% and is now trading at $11.48.
View the best growth stocks for 2023 here.
Are investors shorting WuXi Biologics (Cayman)?: WuXi Biologics (Cayman) saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 3,300 shares, a decrease of 87.6% from the April 30th total of 26,700 shares. Based on an average daily trading volume, of 60,900 shares, the days-to-cover ratio is currently 0.1 days.
View WuXi Biologics (Cayman)'s Short Interest.
What is WuXi Biologics (Cayman)'s stock symbol?: WuXi Biologics (Cayman) trades on the OTCMKTS under the ticker symbol "WXXWY."

How do I buy shares of WuXi Biologics (Cayman)?: Shares of WXXWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is WuXi Biologics (Cayman)'s stock price today?: One share of WXXWY stock can currently be purchased for approximately $11.48.
How many employees does WuXi Biologics (Cayman) have?: The company employs 9,864 workers across the globe.
How can I contact WuXi Biologics (Cayman)?: The official website for the company is www.wuxibiologics.com.cn. The company can be reached via phone at 8651081831205.

This page (OTCMKTS:WXXWY) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial